Rubicon Organics Stock Current Valuation
| ROMJF Stock | USD 0.33 0.02 6.45% |
Valuation analysis of Rubicon Organics helps investors to measure Rubicon Organics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Rubicon Organics' price fluctuation is out of control at this time. Calculation of the real value of Rubicon Organics is based on 3 months time horizon. Increasing Rubicon Organics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Rubicon otc stock is determined by what a typical buyer is willing to pay for full or partial control of Rubicon Organics. Since Rubicon Organics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rubicon OTC Stock. However, Rubicon Organics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.33 | Real 0.28 | Hype 0.33 | Naive 0.3 |
The real value of Rubicon OTC Stock, also known as its intrinsic value, is the underlying worth of Rubicon Organics OTC Stock, which is reflected in its stock price. It is based on Rubicon Organics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Rubicon Organics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Rubicon Organics helps investors to forecast how Rubicon otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rubicon Organics more accurately as focusing exclusively on Rubicon Organics' fundamentals will not take into account other important factors: Rubicon Organics OTC Stock Current Valuation Analysis
Rubicon Organics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Rubicon Organics Current Valuation | 29.99 M |
Most of Rubicon Organics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rubicon Organics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Rubicon Organics has a Current Valuation of 29.99 M. This is 99.79% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.82% higher than that of the company.
Rubicon Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rubicon Organics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Rubicon Organics could also be used in its relative valuation, which is a method of valuing Rubicon Organics by comparing valuation metrics of similar companies.Rubicon Organics is currently under evaluation in current valuation category among its peers.
Rubicon Fundamentals
| Return On Equity | -0.0569 | |||
| Return On Asset | -0.0117 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 29.99 M | |||
| Shares Outstanding | 56.08 M | |||
| Shares Owned By Insiders | 54.29 % | |||
| Shares Owned By Institutions | 1.33 % | |||
| Price To Earning | 5.86 X | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 0.89 X | |||
| Revenue | 22.61 M | |||
| Gross Profit | 1.51 M | |||
| EBITDA | (10.87 M) | |||
| Net Income | (14.52 M) | |||
| Cash And Equivalents | 7.42 M | |||
| Cash Per Share | 0.13 X | |||
| Total Debt | 8.95 M | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 3.75 X | |||
| Book Value Per Share | 0.73 X | |||
| Cash Flow From Operations | (10.44 M) | |||
| Earnings Per Share | (0.17) X | |||
| Number Of Employees | 141 | |||
| Beta | 0.82 | |||
| Market Capitalization | 30.56 M | |||
| Total Asset | 54.84 M | |||
| Z Score | 1.8 | |||
| Net Asset | 54.84 M |
About Rubicon Organics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rubicon Organics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rubicon Organics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rubicon Organics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Rubicon OTC Stock
Rubicon Organics financial ratios help investors to determine whether Rubicon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rubicon with respect to the benefits of owning Rubicon Organics security.